ReviewCancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology2017
The Premenopausal Breast Cancer Collaboration: A Pooling Project of Studies Participating in the National Cancer Institute Cohort Consortium.
Abstract readReview
In one paragraph
Review in Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.
0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
24 citing papers in PubMed.
- Assisted Reproductive Technologies (ART) and breast cancer risk: hormonal treatments under the spotlight.Breast cancer research and treatment · 2026Review
- Accelerating discovery of cancer causes for prevention in the era of rising early-onset cancers.Cell · 2026Review
- Prognosis of Breast Cancer in Women in Their 20s: Clinical and Radiological Insights.Diagnostics (Basel, Switzerland) · 2025Article
- Hormone therapy use and young-onset breast cancer: a pooled analysis of prospective cohorts included in the Premenopausal Breast Cancer Collaborative Group.The Lancet. Oncology · 2025Article
- Development and validation of a risk prediction model for premenopausal breast cancer in 19 cohorts.Breast cancer research : BCR · 2025Article
- Central and peripheral adiposity and premenopausal breast cancer risk: a pooled analysis of 440,179 women.Breast cancer research : BCR · 2025Article
- Comparing survival outcomes between neoadjuvant and adjuvant chemotherapy within hormone receptor-positive, human epidermal growth factor receptor 2-negative early breast cancer among young women (≤35): a retrospective cohort study based on SEER database and TJMUCH registry.American journal of cancer research · 2025Article
- Adiposity throughout Adulthood and Risk of Young-Onset Breast Cancer Tumor Subtypes in the Young Women's Health History Study.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2024Article
- BMI and breast cancer risk around age at menopause.Cancer epidemiology · 2024Article
- International Pooled Analysis of Leisure-Time Physical Activity and Premenopausal Breast Cancer in Women From 19 Cohorts.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2024Article
- Racial and ethnic differences in tumor characteristics among endometrial cancer patients in an equal-access healthcare population.Cancer causes & control : CCC · 2023Article
- Hypertensive conditions of pregnancy, preterm birth, and premenopausal breast cancer risk: a premenopausal breast cancer collaborative group analysis.Breast cancer research and treatment · 2023Article
- The role of interleukin‑7 serum level as biological marker in breast cancer: a cross‑sectional, observational, and analytical study.World journal of surgical oncology · 2022Observational
- Gestational diabetes and risk of breast cancer before age 55 years.International journal of epidemiology · 2022Article
- Theory, methods, and operational results of the Young Women's Health History Study: a study of young-onset breast cancer incidence in Black and White women.Cancer causes & control : CCC · 2021Article
- Tissue-Specific Warburg Effect in Breast Cancer and Cancer-Associated Adipose Tissue-Relationship between AMPK and Glycolysis.Cancers · 2021Article
- Adolescent use of hair dyes, straighteners and perms in relation to breast cancer risk.International journal of cancer · 2021Article
- Article
- The Other Side of Through: Young Breast Cancer Survivors' Spectrum of Sexual and Reproductive Health Needs.Qualitative health research · 2020Article
- Adult weight change and premenopausal breast cancer risk: A prospective pooled analysis of data from 628,463 women.International journal of cancer · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
53 authors.
Hazel B NicholsUniversity of North Carolina, Gillings School of Global Public Health, Chapel Hill, North Carolina. hazel.nichols@unc.edu.
Minouk J SchoemakerDivision of Genetics and Epidemiology, The Institute of Cancer Research, Sutton, United Kingdom.
Lauren B WrightDivision of Genetics and Epidemiology, The Institute of Cancer Research, Sutton, United Kingdom.
Craig McGowanUniversity of North Carolina, Gillings School of Global Public Health, Chapel Hill, North Carolina.
Mark N BrookDivision of Genetics and Epidemiology, The Institute of Cancer Research, Sutton, United Kingdom.
Kathleen M McClainUniversity of North Carolina, Gillings School of Global Public Health, Chapel Hill, North Carolina.
Michael E JonesDivision of Genetics and Epidemiology, The Institute of Cancer Research, Sutton, United Kingdom.
Hans-Olov AdamiKarolinska Institutet, MEB, University of Oslo Institute of Health and Society, Sweden, Norway.
Claudia AgnoliFondazione IRCCS Istituto Nazionale dei Tumori, Italy, France.
Laura BagliettoCentre for Research in Epidemiology and Population Health (CESP), France.
Leslie BernsteinBeckman Research Institute of City of Hope, Monrovia, California.
Kimberly A BertrandSlone Epidemiology Center at Boston University, Boston, Massachusetts.
William J BlotDivision of Epidemiology, Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee.
Marie-Christine Boutron-RuaultCentre for Research in Epidemiology and Population Health (CESP), France.
Lesley ButlerUniversity of Pittsburgh Graduate School of Public Health, University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania.
Yu ChenNYU School of Medicine, New York, New York.
Michele M DoodyRadiation Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, Maryland.
Laure DossusInternational Agency for Research on Cancer, France.
A Heather EliassenChanning Division of Network Medicine, Brigham and Women's Hospital, Harvard T.H. Chan School of Public Health and Harvard Medical School, Boston, Massachusetts.
Graham G GilesCancer Council Victoria, University of Melbourne, Melbourne, Australia.
Inger T GramUniversity of Tromsø, The Arctic University of Norway, Tromsø, Norway.
Susan E HankinsonDepartment of Biostatistics and Epidemiology, School of Public Health and Health Sciences, University of Massachusetts, Boston, Massachusetts.
Judy Hoffman-BoltonJohns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
Rudolf KaaksDivision of Cancer Epidemiology, DKFZ, Heidelberg, Germany.
Timothy J KeyUniversity of Oxford, Oxford, United Kingdom.
Victoria A KirshDalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.
Cari M KitaharaRadiation Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, Maryland.
Woon-Puay KohDuke-NUS Medical School, Singapore.
Susanna C LarssonKarolinska Institutet, Institute of Environmental Medicine, Stockholm, Sweden.
Eiliv LundUiT (University of Tromsø), Tromsø, Norway.
Huiyan MaBeckman Research Institute of City of Hope, Monrovia, California.
Melissa A MerrittSchool of Public Health, Imperial College London, United Kingdom.
Roger L MilneCancer Council Victoria, University of Melbourne, Melbourne, Australia.
Carmen NavarroDepartment of Epidemiology, Murcia Regional Health Council, IMIB-Arrixaca, Murcia, Spain.
Kim OvervadDepartment of Public Health, Section for Epidemiology, Aarhus University, Aarhus, Denmark.
Kotaro OzasaRadiation Effects Research Foundation, Hiroshima, Japan.
Julie R PalmerSlone Epidemiology Center at Boston University, Boston, Massachusetts.
Petra H PeetersUniversity Medical Center, Utrecht, the Netherlands.
Elio RiboliSchool of Public Health, Imperial College London, United Kingdom.
Thomas E RohanAlbert Einstein College of Medicine, Bronx, New York.
Atsuko SadakaneRadiation Effects Research Foundation, Hiroshima, Japan.
Malin SundUmeå University, Umeå, Sweden.
Rulla M TamimiChanning Division of Network Medicine, Brigham and Women's Hospital, Harvard T.H. Chan School of Public Health and Harvard Medical School, Boston, Massachusetts.
Antonia TrichopoulouHellenic Health Foundation, Greece.
Lars VattenNorwegian University of Science and Technology, Trondheim, Norway.
Kala VisvanathanJohns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
Elisabete WeiderpassKarolinska Institutet, Department of Epidemiology and Biostatistics, Oslo, Norway.
Walter C WillettDepartment of Nutrition and Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.
Alicja WolkKarolinska Institutet, Institute of Environmental Medicine, Stockholm, Sweden.
Anne Zeleniuch-JacquotteNYU School of Medicine, New York, New York.
Wei ZhengDivision of Epidemiology, Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee.
Dale P SandlerEpidemiology Branch, National Institute of Environmental Health Sciences, National Institutes of Health, Durham, North Carolina.
Anthony J SwerdlowDivision of Genetics and Epidemiology, The Institute of Cancer Research, Sutton, United Kingdom.
Funding
Virology Research Program (Program 4)P30CA016086 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI David Darr · 1985 to 2026
$201.5MVaccine FacilityP30CA016087 · NCI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI ANIRBAN MAITRA · 1985 to 2026
$83.1MStatistical MethodsP01CA087969 · NCI · BRIGHAM AND WOMEN'S HOSPITAL · PI ROSNER, BERNARD A · 2000 to 2019
$77.8MSouthern Community Cohort StudyR01CA092447 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI BLOT, WILLIAM J., ZHENG, WEI · 2001 to 2015
$74.0MUNC-CH CENTER FOR ENVIRONMENTAL HEALTH &SUSCEPTIBILITYP30ES010126 · NIEHS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Stephanie Engel · 2001 to 2026
$36.3MStudies of Populations Exposed to Occupational Sources of RadiationZIACP010133 · NCI · DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS · PI KITAHARA, CARI · 2009 to 2025
$34.2MCALIFORNIA TEACHERS STUDYR01CA077398 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI BERNSTEIN, LESLIE · 1998 to 2014
$29.7MRESEARCH IN ENVIRONMENTAL HEALTH SCIENCES (CENTER GRANT)P30ES000260 · NIEHS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI ZELIKOFF, JUDITH TERRY · 1985 to 2020
$26.1MEnvironmental and Genetic Risk Factors For Breast Cancer: The Sister StudyZIAES044005 · NIEHS · NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES · PI SANDLER, DALE P · 2009 to 2025
$22.7MLong Term Multidisciplinary Study of Cancer in Women: The Nurses Health StudyUM1CA186107 · NCI · BRIGHAM AND WOMEN'S HOSPITAL · PI ELIASSEN, A. HEATHER, STAMPFER, MEIR · 2014 to 2023
$22.3MFOLLOW-UP STUDY FOR CAUSES OF ILLNESS IN BLACK WOMENR01CA058420 · NCI · BOSTON UNIVERSITY MEDICAL CAMPUS · PI ROSENBERG, LYNN · 1999 to 2013
$20.7MLife Course Cancer Epidemiology Cohort in WomenUM1CA176726 · NCI · HARVARD SCHOOL OF PUBLIC HEALTH · PI WILLETT, WALTER C. · 2013 to 2017
$15.7MCancer Research UK 16491Intramural NIH HHS Z01 ES044005Medical Research Council MC_U137686850NCATS NIH HHS KL2 TR001109NCI NIH HHS P01 CA087969NCI NIH HHS P30 CA016086NCI NIH HHS P30 CA016087NCI NIH HHS R01 CA058420NCI NIH HHS R01 CA077398NCI NIH HHS R01 CA092447NCI NIH HHS R01 CA144034NCI NIH HHS UM1 CA164974NCI NIH HHS UM1 CA176726NCI NIH HHS UM1 CA182876NCI NIH HHS UM1 CA182934NCI NIH HHS UM1 CA186107NIEHS NIH HHS P30 ES000260NIEHS NIH HHS P30 ES010126World Health Organization 001
Abstract
Breast cancer is a leading cancer diagnosis among premenopausal women around the world. Unlike rates in postmenopausal women, incidence rates of advanced breast cancer have increased in recent decades for premenopausal women. Progress in identifying contributors to breast cancer risk among premenopausal women has been constrained by the limited numbers of premenopausal breast cancer cases in individual studies and resulting low statistical power to subcategorize exposures or to study specific subtypes. The Premenopausal Breast Cancer Collaborative Group was established to facilitate cohort-based analyses of risk factors for premenopausal breast cancer by pooling individual-level data from studies participating in the United States National Cancer Institute Cohort Consortium. This article describes the Group, including the rationale for its initial aims related to pregnancy, obesity, and physical activity. We also describe the 20 cohort studies with data submitted to the Group by June 2016. The infrastructure developed for this work can be leveraged to support additional investigations.
Indexed as
Breast NeoplasmsAdultCohort StudiesFemaleHumansMiddle AgedNational Cancer Institute (U.S.)PremenopauseUnited States
Identifiers
What OpenQuestion holds
Textmetadata
LicenceTDM
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.